Vitamin B12 Acceptance and Biomarker Response Study

PHASE4CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Vitamin B 12 Deficiency
Interventions
DRUG

Oral administration of vitamin B12

Daily high dose oral vitamin B12 (1mg) will be administered over 4 weeks. The patients adherence to this regimen will be monitored with an electronic punch card.

DRUG

i.m. injection of vitamin B12

Intramuscular injections of 1 mg vitamin B12 will be performed at days 7, 14, and 21.

Trial Locations (1)

CH-4056

Pharmaceutical Care Research Group, Basel

All Listed Sponsors
collaborator

University of Basel

OTHER

collaborator

Aarelab AG

INDUSTRY

lead

University Hospital, Basel, Switzerland

OTHER

NCT01832129 - Vitamin B12 Acceptance and Biomarker Response Study | Biotech Hunter | Biotech Hunter